(Q81493514)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15754736%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Treatment of acromegaly with SS analogues: should GH and IGF-I target levels be lowered to assert a tight control of the disease? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15754736%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15754736%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

R Cozzi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15754736%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

S Grottoli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15754736%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

G Pagani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15754736%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

P Loli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15754736%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

V Gasco

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15754736%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

A M Pedroncelli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15754736%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

M Montini

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15754736%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

E Ghigo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15754736%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15754736%20AND%20SRC:MED&resulttype=core&format=json

Journal of Endocrinological Investigation

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15754736%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15754736%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15754736%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

1040-1047

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15754736%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf03345307

9 January 2020

exact match

0 references

cites work

Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

1 reference

12 December 2020

Determinants of clinical outcome and survival in acromegaly

1 reference

12 December 2020

Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels

1 reference

12 December 2020

Growth-hormone and prolactin excess.

1 reference

12 December 2020

Estroprogestinic pill normalizes IGF-I levels in acromegalic women.

1 reference

12 December 2020

Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly

1 reference

12 December 2020

The role of circulating IGF-I: lessons from human and animal models

1 reference

12 December 2020

Current treatment guidelines for acromegaly

1 reference

12 December 2020

Sandostatin LAR in acromegalic patients: long-term treatment

1 reference

12 December 2020

Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study

1 reference

12 December 2020

Estradiol treatment of acromegaly. Reduction of immunoreactive somatomedin-C and improvement in metabolic status

1 reference

12 December 2020

Lanreotide 60 mg, a New Long-Acting Formulation: Effectiveness in the Chronic Treatment of Acromegaly

1 reference

12 December 2020

Long-term treatment outcome in acromegaly

1 reference

12 December 2020

Current concepts in the biochemical assessment of the patient with acromegaly

1 reference

12 December 2020

Somatostatin analogs in acromegaly

1 reference

12 December 2020

Men with acromegaly need higher doses of octreotide than women

1 reference

12 December 2020

Three year follow-up of acromegalic patients treated with intramuscular slow-release lanreotide

1 reference

12 December 2020

Factors influencing mortality in acromegaly

1 reference

12 December 2020

Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly

1 reference

12 December 2020

Biochemical monitoring of disease activity after surgery for acromegaly

1 reference

12 December 2020

GH/IGF-I normalization and tumor shrinkage during long-term treatment of acromegaly by lanreotide.

1 reference

12 December 2020

Raloxifene lowers IGF-I levels in acromegalic women.

1 reference

12 December 2020

The somatomedin hypothesis: 2001.

1 reference

12 December 2020

Seeking the optimal target range for insulin-like growth factor I during the treatment of adult growth hormone disorders

1 reference

12 December 2020

The relationship between serum GH and serum IGF-I in acromegaly is gender-specific

1 reference

12 December 2020

Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegaly

1 reference

12 December 2020

Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in the management of acromegaly

1 reference

12 December 2020

Criteria for cure of acromegaly: a consensus statement

1 reference

12 December 2020

Effects of ingestion of glucose on GH and TSH secretion: evidence for stimulation of somatostatin release from the hypothalamus by acute hyperglycemia in normal man and its impairment in acromegalic patients

1 reference

12 December 2020

Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women

1 reference

12 December 2020

Gender- and age-related differences in the endocrine parameters of acromegaly

1 reference

12 December 2020

Guidelines for acromegaly management

1 reference

12 December 2020

Mortality in acromegaly

1 reference

12 December 2020

[Treatment of acromegaly with sustained-release lanreotide. A new somatostatin analog]

1 reference

12 December 2020

Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up

1 reference

12 December 2020

Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements

1 reference

12 December 2020

Gender and age influence the relationship between serum GH and IGF-I in patients with acromegaly

1 reference

12 December 2020

Lanreotide 60 mg, a longer-acting somatostatin analog: tumor shrinkage and hormonal normalization in acromegaly.

1 reference

12 December 2020

Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group.

1 reference

12 December 2020

An audit of outcome of treatment in acromegaly.

1 reference

12 December 2020

Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?

1 reference

12 December 2020

Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicenter study. Italian Multicenter Slow Release Lanreotide Study Group

1 reference

12 December 2020